Proliferation of peritoneal mast cells in the skin of W/Wv mice that genetically lack mast cells by unknown
PROLIFERATION  OF  PERITONEAL  MAST  CELLS  IN  THE 
SKIN  OF  W/W v  MICE  THAT  GENETICALLY  LACK 
MAST  CELLS* 
BY  T.  SONODA,  Y.  KANAYAMA,  H.  HARA,  C.  HAYASHI,  M.  TADOKORO, 
T.  YONEZAWA,  AND  Y.  KITAMURA 
From the Institute for Cancer Research and Second Department of Internal Medicine, Osaka 
University Medical School, Kita-ku,  Osaka, 530; and Division of Blood Transfusion,  Hyogo 
College of Medicine, Nishinomiya-city, Hyogo, 663Japan 
Peritoneal  mast  cells  and  macrophages  are  commonly used  to  study  func- 
tions of these two types of cells (1-3).  Although many investigators have studied 
the production of peritoneal macrophages both in vivo (4-6) and in vitro (7, 8), 
only a  few investigators have taken an interest in production of peritoneal mast 
cells (9-11).  Both mast cells and macrophages are the progeny of the multipo- 
tential hematopoietic stem cell (CFU-S) ~ (12,  13).  Although most of the progeny 
of CFU-S  (such as erythrocytes, neutrophils,  and platelets) differentiate within 
hematopoietic tissues, undifferentiated precursors of mast cells leave the hema- 
topoietic tissues, migrate in the peripheral blood (14-16),  and enter connective 
tissues, where they proliferate, and differentiate into mast cells (17-19).  Such a 
mode of differentiation bears some resemblance to that of macrophages, because 
monocytes, the precursors  of macrophages, often undergo final differentiation 
in  nonhematopoietic  tissues  (20).  Since  Lin  and  his  co-workers  (7,  8)  have 
demonstrated the presence of macrophage precursors in the peritoneal cavity of 
mice and have characterized such precursors, we examined the presence of mast 
cell precursors in the peritoneal cavity. For this purpose, we used mice of W/W  v 
genotype as recipients of cells, because these mutant mice genetically lack tissue 
mast cells (21, 22). When a cell suspension, containing mast cell precursor(s), was 
injected directly into the skin of W/W  v mice, a cluster of mast cells appeared at 
the injection site (16).  By determining the proportion of injection sites at which 
mast cells appeared,  the concentration of mast cell precursors can be calculated 
with the limiting dilution analysis. Unexpectedly, the concentration of mast cell 
precursors  in  the  peritoneal  cavity was  about  five times as  great  as  the  value 
observed in the bone marrow.  Physical characterization revealed that mast cell 
precursors in the peritoneal cavity differed from mast cell precursors in the bone 
marrow. When a single peritoneal mast cell was picked by the micromanipulator 
and injected into the skin of W/W  v mice, a  mast cell cluster containing ~2,000 
This work was supported by grants from the Ministry  of Education,  Science  and Culture, the Ministry 
of Health and Welfare, the Mitsubishi Foundation, and the Princess Takamatsu Cancer Research 
Fund. Correspondence should be addressed to Y. Kitamura, Institute for Cancer Research, Osaka 
University Medical School, Nakanoshima  4-3-57, Kita-ku,  Osaka, 530 Japan. 
Abbreviations used in this paper:  BSA,  bovine serum albumin; CFU-S, spleen colony-forming 
unit. 
1  38  J. ExP. MED. © The Rockefeller University  Press - 0022-1007/84/07/0138/14  $1.00 
Volume 160  July 1984  138-151 SONODA  ET  AL.  139 
cells developed at 6%  injection  sites.  This  indicated  that  some peritoneal  mast 
cells kept extensive proliferative potentiality even after morphological differen- 
tiation. 
Materials and  Methods 
Mice.  Mice of (WB ×  C57BL/6)F~ (hereafter WBB6F~)-(W/W ~, W/+, WV/+, +/+) and 
C57BL/6-(bgJ/bg y, +/+) were raised in our laboratory. Giant granules of C57BL/6-bgJ/ 
bg  J mice were used as a marker to identify the origin of mast cells (23, 24). Original stocks 
of mutant mice were derived from The Jackson Laboratory, Bar Harbor, ME,  but  W  v 
and bg  J mutant genes have been maintained in C57BL/6 mice of our own inbred colony 
(more than  28 and  15  backcrosses, respectively at the time of the present experiment) 
(25, 26). Mice were used at 2-6 months of age. 
Cell Suspensions.  Mice were killed by decapitation. 2 ml of Eagle's medium containing 
10 IU/ml heparin and 0.1% bovine serum albumin (BSA) was injected into the peritoneal 
cavity, and the abdomen was massaged gently for 30 s. The peritoneal cavity was then 
carefully opened, and the fluid containing peritoneal cells was aspirated with a pasteur 
pipette.  Cells from bone marrow were suspended  in  Eagle's medium according to the 
method described previously (27). 
Cell Counts.  Number of cells was determined with a standard hemocytometer. Mast 
cells were identified either by staining with toluidine blue solution containing  1% acetic 
acid or by using the phase contrast microscope. Both methods gave satisfactory agreement. 
However, when  the proportion of mast cells in  the examined cell suspension  was low, 
mast cells were accurately counted only after staining with toluidine blue. 
Removal  of Phagocytes.  The major components of mouse peritoneal cells are macro- 
phages and  small  lymphocytes.  Macrophages  were  removed according to  the  method 
described by Kubota et al. (28).  The peritoneal cell suspension was adjusted to 5  ×  106 
cells/ml.  Carbonyl  iron  (GAF Co.,  New York)  was added  to  this suspension  at a  final 
concentration of 4 mg/ml and the mixture was incubated in a water bath at 37°C. Then 
the mixture was agitated frequently for 30  rain and the iron and iron-laden cells were 
attracted to the bottom of a tube by using a magnet (9,000 gauss). The ceils remaining in 
the supernatant fluid were used for nonphagocytic cells. 
Density Gradient  Centrifugation.  Peritoneal and bone marrow cells were fractionated 
on  continuous  density  gradients  according  to  the  method  described  by  N~meth  and 
R6hlich (29) and Enerbfick and Svensson (:30) with a slight modification. Stock solutions 
(1.12  g/ml) of polyvinylpyrolidone-coated silica  particles (Percoll,  Pharmacia,  Uppsala) 
were prepared by dissolving 9 parts of Percoll with 1 part of 10-fold concentrated calcium- 
and magnesium-free Hanks' solution containing 1% BSA and 200 mM N-2-hydroxyethyl- 
piperazine-N'-2-ethanesulfonic acid (Hepes). Continuous density gradients of Percoll were 
generated by centrifugation of 7 ml of Percoll stock solution with 23,000 g for 60 min at 
4°C in a  Hitachi RP-65 fixed angle roter.  Gradients ranging from a density of 1.03  to 
1.90 were obtained by this procedure.  1 ml of suspensions containing 2  ×  10 7 cells was 
carefully layered on top of Percoll continuous gradients, and centrifugation was performed 
with 500 g for 30 min at 4°C in a swing-out rotor. Percoll gradient solution (0.4 ml each) 
was collected from the bottom of the tube by the peristaltic pump. Cells were washed and 
resuspended in Eagle's medium. Mast cell suspension (30-50% pure) were obtained by a 
single centrifugation of the phagocyte-free peritoneal cells. 
To obtain  mast cell suspensions of >90%  purity, the above-mentioned procedure of 
density gradient centrifugation was repeated by using 30-50% pure mast cell suspensions. 
In this case,  1 ml of suspension containing 2 ×  l0 s cells was layered on top of the Percoll 
continuous gradients. 
Separation of a Single Mast Cell by Micromanipulator.  Peritoneal cell suspensions con- 
taining 30-50%  mast cells were prepared by the removal of phagocytes and the density 
gradient centrifugation. Cells other than mast cells were mostly small lymphocytes. The 
concentration  was adjusted  to  5  ×  10 4  cells per  ml.  One  drop of the  suspension  was 
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separated, and individually aspirated with a fine microtube attached to a  Leitz microma- 
nipulator.  An  aspirated  single  mast  cell  was  individually  transferred  to  a  plastic  tube 
(#2003  Falcon  Plastics,  Becton  Dickinson  Overseas  Inc.,  Tokyo)  containing  0.05  ml 
Eagle's medium.  In another experiment,  10 individually aspirated mast cells were trans- 
ferred to a plastic tube. 
Direct Injection of Cells into the Skin.  Hairs of dorsal skin of WBB6F1-W/W  ~ mice were 
removed with hair clippers. Cells in 0.05 ml Eagle's medium were injected directly into 
the skin with a tuberculine syringe. Each mouse received six injections, the sites of which 
were marked  by mixing India ink with  the suspension  medium.  Mice were killed  5  wk 
after the cell injection. The dorsal skin was peeled off; each injection site that could be 
identified as a blotted black spot was cut to 1.5 ×  1 cm, attached to a piece of thick filter 
paper to keep it fiat, and fixed in 10% buffered formalin (pH 7.2). Skins were embedded 
in paraffin; serial sections (25 ~m thick, cut parallel to the skin surface), were cut from 
the subcutaneous tissue to the epithelium,  and stained with acidified toluidine blue (pH 
3.0) (31).  All serial  sections were examined using a  microscope. A  group of more than 
100 mast cells at the largest cross sections was defined as a mast cell cluster. The maximum 
number of clusters that could be identified at each injection site was three. 
Limiting Dilution Analysis.  The principle of the method has been described in detail 
(16). When at least one mast cell cluster appeared, the injected cell suspension was assumed 
to contain  mast  cell precursor(s).  Concentration  of mast cell  precursors  was calculated 
from the proportion of injection sites at which no clusters appeared (defined as "proportion 
of nonappearance") for various cell doses by limiting dilution analysis according to Finney 
(32), Porter and Berry (33), and Breivik (34). 
Electron Microscopy.  Peritoneal cells of WBB6F1-+/+ mice were mixed with India ink 
and directly injected into the skin of WBB6F1-W]W ~ mice. The WBB6F~-W/W  v mice were 
killed 5 wk after the injection. Each injection site, which was identified as a  blotted black 
spot, was diced into fragments (~ 1 mm  3) using scissors. The fragments were fixed with 
3% glutaraldehyde in 0.1  M cacodylate buffer (pH 7.4) at room temperature for 45 min, 
and were washed with 0.1 M cacodylate buffer containing 4.5% sucrose. After postfixation 
with  1% osmium tetroxide in Veronal acetate buffer (pH 7.4) for 1 h at 4°C, the tissue 
fragments  were  dehydrated  in  a  graded  series  of ethanol  followed  by  acetone,  and 
embedded in Epon 812. Ultrathin sections were cut with the LKB ultramicrotome, stained 
with  uranyl  acetate  and  lead  citrate,  and  examined  with  a  Hitachi  HU-12  electron 
microscope. 
Irradiation.  A Toshiba X-ray machine was operated at  180 kV and 20 mA with a  l- 
mm aluminum filter.  Mice were kept in a polycarbonate box during irradiation.  Target 
distance was 72 cm when mice received <850  rad (61  rad/min),  and 45 cm when mice 
received >1,200 rad (155 rad/min).  When peritoneal cells of irradiated  mice were used, 
the cells were harvested within  1 h after irradiation for transplantation. 
Assay of Spleen  Colony-forming Unit (CFU-S).  The method of Till and  McCulloch (35) 
was used to determine the number of CFU-S (35). Peritoneal cells (2 x  106) from WBB6F,- 
+/+ mice were injected intravenously into WBB6F1-(+/+, W/+, or W~/+) mice exposed 
to  850  rad.  The  mice  were  killed  on  the  eighth  day after  the  injection;  spleens  were 
removed and fixed in Bouin's solution. Colonies were counted with a dissection microscope 
(x 7). More than 10 mice were used to determine each value. 
Origin of  Mast Cell Precursors.  Origin of mast cell precursors were determined by using 
giant granules of bgJ/bg  J mice as a marker (22, 24). In one experiment, bone marrow cells 
of C57BL/6-bgJ/bg J  mice  were  injected  intravenously  to nonirradiated  WBB6F1-W/W  v 
mice. Two months after the transplantation,  peritoneal cells of WBB6FI-W/W ~ recipients 
were harvested,  and injected into the skin of the other WBB6F~-W/W  ~ mice. 5 wk after 
the injection, types of mast cells that appeared at the injection sites were examined (Fig. 
1a). 
In another experiment, types of mast cell precursors in the peritoneal cavity, peripheral 
blood, and  bone marrow of C57BL/6-+/+  recipients  were determined  2  months after 
irradiation  (800  rad) and  bone marrow  transplantation  from C57BL/6-bgl/bg J  donors. 
Cell suspensions were prepared  from the above-mentioned tissues and injected into the SONODA  ET  AL. 
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FIGURE  1.  Experimental design for the origin of mast cell precursors. Giant granules of mast 
cells of bgl/bg 1 mice were used as a marker. 
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FIGURE 9.  Proportion of injection sites at which mast cells did not appear 5 wk after direct 
injection of different numbers  of peritoneal cells from WBB6F,-+/+  mice. Each value was 
obtained by examining 42-48 injection sites.  The logarithmic regression line is described by 
the equation In p  =  -0.48 X  10 -s X -  0.08 (p =  proportion of nonappearance; X =  number 
of cells). The regression line for bone marrow cells (16) is also shown for comparison. 
skin of WBB6F,-W/W  ~ mice. 5  wk after the injection, types of mast cells that appeared at 
the injection sites were determined (Fig.  1 B). 
Results 
Presence  of Mast  Cell  Precursors  in  the  Peritoneal  Cavity.  Various  doses  of 
peritoneal  cells of WBB6FI-+/+  mice  were directly  injected  into  the  skin  of 
WBB6F]-W/W  ~ mice, and the development of mast cells at the injection sites was 
examined.  The  concentration  of mast  cell  precursors  was  calculated  by  the 
limiting dilution analysis (Fig. 2). The concentration in the peritoneal cavity was 
-5  times  as  much  as  the  value  observed  in  the  bone  marrow  (Table  I).  In 142  PROLIFERATION  OF  PERITONEAL  MAST  CELLS 
TABLE  I 
Concentration of CFU-S and Mast Cell Precursors in the Peritoneal 
Cavity and Bone Marrow of WBB6Fl-+/+ 
Mean no. per 105 cells* 
Origin of cells  Mast cell precur- 
CFU-S 
sor 
Peritoneal cavity  0.21  (0.16-0.26)  48 (42-55) 
Bone marrow*  20  (18-22)  10 (8-12) 
* The 95% confidence intervals are shown in parentheses. 
* Data that have been reported by us (16) are shown for comparison. 
contrast,  the concentration of CFU-S  in  the peritoneal  cavity was much lower 
than  the  concentration  in  the  bone  marrow  (Table  I).  This  suggested  that 
peritoneal precursors  measured by the present method were committed to the 
mast cell differentiation. 
When the concentration of mast cell precursors was measured by the limiting 
dilution analysis, only the appearance of >100 mast cells was questioned. How- 
ever, when mast cells appeared at injection sites, they usually appeared in groups 
(Fig. 3A). Although the largest cluster contained ~8,000 mast cells, usual clusters 
contained ~2,000  mast cells.  We examined the clonal nature of these mast cell 
clusters.  Peritoneal cells from C57BL/6-bgJ/bg  J mice (5  x  103) and those from 
C57BL/6-+/+ mice (5 x  103) were mixed and injected into the skin of WBB6F1- 
W/W  v mice; a total of 179 clusters developed in  144 injection sites. As shown in 
Table II, most clusters contained either bgJ/bgJ-type mast cells alone (Fig. 3B) or 
+/+-type mast cells alone (Fig. 3 C). This indicated that the development of mast 
cell clusters resulted from proliferation and differentiation of a single precursor 
rather than from aggregation of differentiated mast cells. 
Electron microscopy was used to confirm that the cells, appearing in the skin 
after the direct injection of peritoneal cells, were in fact mast cells. As shown in 
Fig. 3D,  the nucleus was not segmented; cytoplasmic granules were numerous, 
small and electron dense. These characteristics are consistent with the ultrastruc- 
tural  features of the  mature  mast cell,  which have been  described  by Zucker- 
Franklin (36), Galli et al. (37), and Dvorak et al. (38). 
Since  mast cell precursors  in  nonhematopoietic tissues such as the  skin (39) 
and the lymph node (31) have been shown to originate from the bone marrow, 
we examined whether peritoneal mast cell precursors were also derived from the 
bone marrow (Fig. 1A). Bone marrow cells (2 x  107) from C57BL/6-bgJ/bg  J mice 
were  injected intravenously into the WBB6F1-W/W  v mice.  The  first recipients 
were  killed  2  months after the  bone  marrow  transplantation;  peritoneal  cells 
were harvested and divided into two aliquots.  One was  used to determine the 
concentration of differentiated mast cells and the other to examine the presence 
of mast cell precursors.  Mast cells of bgJ/bg  J type were observed in the peritoneal 
cavity of the first recipients. When the peritoneal cells of the first recipients were 
injected into the skin of the second WBB6F1-W/W  ~ recipients, clusters containing 
only bgJ/bgJ-type mast cells appeared at the injection sites. This clearly indicated 
the bone marrow origin of peritoneal mast cells and peritoneal mast cell precur- 
sors. FIGURE  3.  (A) A  mast cell cluster that developed in the skin of WBB6FI-W/W  ~ mice 5  wk 
after injection of peritoneal cells from WBB6FI-+/+ mice, stained with toluidine blue, x  87. 
(B) A part of the cluster containing only bgl/bgJ-type mast cells, stained with toluidine blue, × 
590. (C) A part of the cluster containing only +/+-type mast cells, stained with toluidine blue, 
×  590. (D) The ultrastructure of a mast cell that developed in the skin of WBB6Ft-W/W  v alice 
5 wk after injection of peritoneal cells from WBB6FI-+/+ mice, x  8,800. 
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TABLE  II 
Constitution of Mast Cell Clusters Detected in the Skin of WBB6F1- 
W/W  v Mice 5 Wk after Direct Injection of a Mixture of Peritoneal 
Cells  from C57BL/6-bgl/bg  I Mice and C57BL/6-+/+ Mice* 
Type of clusters  No. of clusters 
Cluster containing bg//bgLtype alone  98 
Cluster containing +/+-type alone  73 
Cluster containing both types  8 
Total  s  179 
* 5 X  10  s peritoneal  cells from C57BL/6-bgl/bg  I mice and  5  x  10  s 
peritoneal cells of C57BL/6-+/+ mice were mixed. 
* Total 179 clusters appeared in 144 injection sites. 
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FIGURE 4.  Effect of irradiation on the concentration of mast cell precursors in the peritoneal 
cavity of WBBGFr+/+ mice. The Do value (dose required to reduce the surviving fraction by 
a factor of 0.37) is 565 + 51 rad, Each value was obtained by examining 64-92 injection sites. 
The result about mast cell precursors in the bone marrow is also shown for comparison; Do 
value for bone marrow precursors is 123 + 9 rad (40), 
Difference between Peritoneal and Bone Marrow Mast Cell Precursors.  Although 
mast cell precursors localized in the skin originate from the bone marrow,  the 
biological  characters  of skin  precursors  are  different  from  those  of marrow 
precursors (18, 26, 40). We compared the characters of the peritoneal precursors 
to those of marrow precursors.  First,  we measured the radiosensitivity of peri- 
toneal precursors. Peritoneal cells were removed from 200- to 1,600-rad-irradi- 
ated  WBB6FI-+/+  mice;  concentrations  of  mast  cell  precursors  in  the  cell 
suspensions  were  measured  by  the  limiting  dilution  analysis;  proportion  of 
surviving precursors were plotted against  radiation  doses.  As  shown in  Fig.  4, 
peritoneal precursors were less susceptible to irradiation than marrow precursors. 
Low radiation sensitivity of peritoneal mast cell precursors were also demon- 
strated in another experiment (Fig.  1 B). Radiation chimeras were produced by 
grafting bone marrow  cells (2  ×  107) of C57BL/6-bgl/bg I  mice into  800-rad- 
irradiated C57BL/6-+/+ mice. Cells were harvested from the peritoneal cavity, 
the peripheral blood, and the bone marrow of C57BL/6-+/+ recipients 2 months 
after the transplantation.  The cells from each tissue were injected into the skin 
of WBB6FI-W/W  ~ mice, and  types of mast cells that appeared at the injection 
sites were examined.  Mast cells of bgJ/bgl-type appeared at the injection sites of 
bone marrow  cells and at the injection sites of peripheral blood cells,  whereas 
mast cells of +/+-type appeared at the injection sites of peritoneal cells (Table 
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TABLE III 
Survival of Host-type Mast Cell Precursors in the Peritoneal Cavity of 
C57BL/6-+/+ Mice 2 Months after 800 rad Irradiation  and 
Injection of 2 x  107 Bone Marrow Cells  from C57BL/6-bgl/bg  j 
Mice* 
Tissues 
No. of  Proportion of injection sites at which 
cells in-  mast cells of each type appeared 
jected  (x 105)  bgl/bgL  +/+-type  Both 
type alone  alone  types 
Peritonealcavity  1  0/48  47/48  1/48 
Peripheral blood  10  31/32  0/32  1]32 
Bone marrow  5  32/32  0/32  0/32 
* Experimental procedures is shown in Fig. 1A. 
TAnLE  IV 
Comparison of Density between Peritoneal and Bone Marrow Mast 
Cell Precursors of WBB6Fr+/+ Mice* 
Origin of cells 
Proportion of injection sites at which 
mast cells appeared* 
Light fraction  Heavy fraction 
(_-<1.07 g/ml)  (i~1.09 g/ml) 
Peritoneal cavity  7/40  37/37 
Bone marrow  19/32  3/48 
* Peritoneal cells and bone marrow cells were separated by density gra- 
dient  centrifugation;  fractions lighter  than  1.07 g/ml  and  fractions 
heavier than  1.09 g/ml  were pooled, respectively. 5 ×  l0  s cells were 
injected into the skin of WBB6FI-W/W  ~  mice. 
* P < 0.01, when compared between peritoneal cavity and bone marrow 
by X  ~ test. 
peripheral blood, mast cell precursors of the host origin were maintained in the 
peritoneal cavity 2 months after 800 rad of whole body irradiation. 
In  the  next  experiment,  the  density  of peritoneal  mast  cell  precursors  was 
compared to that of bone marrow precursors. Peritoneal and bone marrow cells 
of WBB6F~-+/+ mice were fractionated by density gradient centrifugation. Cells 
in  light fractions (-<1.07 g/mi) and those in  heavy fractions (->1.09 g/ml) were 
pooled, respectively; cells in middle fractions were discarded.  Then, cells from 
the light fractions and those from the heavy fractions were injected into the skin 
of WBB6F~-W/W  v mice. Mast cell precursors in the peritoneal cavity were more 
commonly observed in the heavy fractions, whereas mast cell precursors in the 
bone marrow were more commonly observed in the light fractions (Table IV). 
Separation  of Peritoneal Mast Cell Precursors.  Mast  cells accounted for only 
0.5%  of mouse peritoneal cells.  Since the proportion of both morphologically 
identifiable mast cells and mast cell precursors increased in the heavy fraction of 
peritoneal  cells,  we  investigated  the  relationship  between  differentiated  mast 
cells and  mast  cell  precursors.  Since  macrophages  and  small  lymphocytes are 
major  components  of mouse  peritoneal  cells,  macrophages  that  phagocytized 
carbonyi iron were firstly omitted.  The proportion of both differentiated mast 146  PROLIFERATION  OF  PERITONEAL  MAST CELLS 
TABLE V 
Concentration of MorphologicaUy Identifiable Mast Cells and Mast Cell Precursors in 
Fractionated Peritoneal Cells of WBB6Ft-+ / + Mice 
Mean number per 10  ~  cells  Mast  cell/ 
Experi-  Cells examined  precusor 
ment  Mast cells  Precursors  ratio 
Nontreated peritoneal cells  520  51  10 
Peritoneal cells without phagocytes  1,610  136  12 
Mast cell-poor fraction*  60  6.7  9 
Mast cell-rich fraction*  92,000  4,980  19 
Nontreated peritoneal cells  620  53  12 
Mast cell-rich fraction*  95,000  5,810  16 
* Mast ceil-poor and -rich fractions were separated by density gradient centrifugation after removal 
of phagocytes. To obtain the mast cell-rich  fraction, density gradient centrifugation should be 
carried out two times. 
TABLE VI 
Development of Mast Cell Cluster at the Injection Site of 
Morphologically Identified Mast Cell* 
No. of mast cells injected  Proportion of injection site at which 
mast cells appeared 
1  10/168 
10  9/20 
* The mast cell was individually  picked up by the micromanipulator. 
cells and mast cell precursors was tripled by the removal of macrophages (Table 
V). 
Then,  small  lymphocytes and  mast  cells were separated  by density  gradient 
centrifugation.  Each  fraction  was  examined  for the  proportion  of mast  cells; 
fractions that  scarcely contained  mast  cells and  fractions composed mostly  of 
mast cells were selected.  Concentrations of mast  cell precursors in  "mast cell- 
poor" and  "mast cell-rich"  fractions were  determined by the  limiting  dilution 
analysis. For example, mast cell clusters appeared at 21  out of 32 injection sites 
of 20  cells from 95%  pure  mast  cell fraction.  Most  clusters  contained >1,000 
mast  cells.  The  concentration  of mast  cell  precursors  roughly  paralleled  the 
concentration of morphologically identifiable mast cells.  This suggested  that a 
part of morphologically identifiable mast cells possessed remarkable proliferative 
potentiality. 
Injection of a Single Mast Cell into the Skin.  Practically, it was impossible to get 
100% pure mast cell fraction by the removal of phagocytes and density gradient 
centrifugation.  Thus,  we picked up a  differentiated mast cell by the  microma- 
nipulator, and injected it directly into the skin of WBB6F1-W/W  v mice. Mast cell 
clusters  developed  in  10  out  of  168  injection  sites  (Table VI).  The  mast  cell 
clusters contained 401-4,408  mast  cells (mean  +  SE,  1,918  +  436).  When  10 
mast  cells  were  collected  by  the  micromanipulator  and  injected  into  a  single 
injection site,  mast  ceil clusters appeared  in  9  out of 20  injection sites  (Table 
VI).  This  clearly  indicated  that  some  morphologically  identifiable  mast  cells 
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Discussion 
The present result clearly demonstrated the presence of mast cell precursors 
in  the peritoneal  cavity of mice.  The electron  microscopic features of the cell, 
which appeared at the injection site of the peritoneal precursor, were consistent 
with the characteristics  of the mature  mast cell described by Zucker-Frankline 
(36),  Galli  et al.  (37),  and  Dvorak et al.  (38).  Since a  mast  cell cluster derived 
from  a  single  peritoneal  precursor  contained  ~2,000  cells,  its  proliferative 
potentiality was comparable to that of the mast cell precursor in the bone marrow 
(19).  Although  the peritoneal  mast cell precursors were derived from the bone 
marrow,  the concentration  of mast cell precursors  in  the peritoneal  cavity was 
about five times as high as the concentration in the bone marrow. Moreover, the 
physical character of peritoneal precursors is different from that of bone marrow 
precursors.  The  peritoneal  precursors  were  heavier  than  the  bone  marrow 
precursors. The former were more resistant to irradiation  than the latter. Since 
the presence of mast cell precursors in the peripheral blood has been shown (14- 
16), the bone marrow-derived precursors seemed to migrate in the circulation, 
enter  into  the  peritoneal  cavity,  proliferate,  and  differentiate  into  peritoneal 
precursors. 
When  bone marrow cells of C57BL/f-bgJ/bg  J mice were injected into intact 
WBBfF~-W/W v mice,  mast cell precursors of bgJ/bgJ-type  appeared in the peri- 
toneal  cavity.  In  contrast,  when  bone  marrow  cells  of C57BL/6-bKJ/bg  J mice 
were injected into irradiated C57BL/8-+/+ mice, mast cell precursors of bgJ/bg  g 
type did not appear  in  the peritoneal  cavity.  This suggests that  the circulating 
precursor of mast cells did not enter the peritoneal cavity that contains sufficient 
number of mast cell precursors. A similar phenomenon was observed in the skin 
of mice  (39).  The  mechanism  that  regulates  this  phenomenon  remains  to  be 
clarified. 
Czarnetski  et al. (11) have also shown the presence of mast cell precursors in 
the peritoneal cavity of rats. They obtained mast cell-depleted peritoneal cells 5 
d after intraperitoneal  injection of distilled water. Mast cells appeared 2 wk after 
starting  the  culture  of such  mast  cell-depleted  peritoneal  cells.  Since  most of 
mast ceil-depleted peritoneal ceils showed phagocytic activity at the start of the 
culture,  they claimed  that  mononuclear  phagocytes were mast cell  precursors 
(11).  In this point, their result is not consistent with the present result,  because 
the removal of phagocytic ceils increased the concentration of mast cell precur- 
sors (Table V). At present, we cannot explain the discrepancy. A single cell with 
phagocytic activity should be picked up, and its differentiation potentiality should 
be examined for further clarification of this problem. 
When  peritoneal  mast cells were purified  by the removal of phagocytes and 
the density gradient  centrifugation,  1 out of 16 cells from 95% pure mast cell 
fraction  could  make  a  mast  cell  cluster  in  the  skin  of WBB6F1-W/W  ~ mice. 
Moreover, 1 out of 17 mast cells that were morphologically identified and picked 
up by the micromanipulator could also make a mast cell cluster. Therefore, some 
morphologically identifiable mast cells in the peritoneal cavity may function as 
the mast cell precursors.  Since peritoneal mast cells appear to float in the fluid, 
the  proliferative  potentiality  of some peritoneal  mast  cells reminds  us of the 
suspension culture system of mast cell-like cells that  has been devised in many 148  PROLIFERATION  OF  PERITONEAL  MAST  CELLS 
laboratories (41-46). However, mitosis of  peritoneal mast cells is seldom observed 
in  intact animals (10).  Moreover,  peritoneal mast  cells  are  typical connective 
tissue  mast  cells,  whereas  mast  ceil-like  cells  in  the  suspension  culture  are 
considered to resemble  mucosal  mast  cells  (47).  Biochemical, functional, and 
immunological characterization revealed the difference between connective tis- 
sue  mast cells and mucosal mast cells (47,  48).  There is a  possibility that the 
peritoneal mast cell with proliferative potentiality may have characteristics similar 
to mast cell-like cells that developed in vitro. A method for separating prolifer- 
ative mast ceils from nonproliferative ones is necessary for further clarification. 
Summary 
Presence of mast cell precursors in the mouse peritoneal cavity was demon- 
strated, and the precursors were characterized. When a cell suspension, contain- 
ing mast cell precursor(s), was directly injected into the skin of genetically mast 
cell-deficient WBB6FI  (WB  X  C57BL/6)-W/W  v  mice,  a  cluster composed  of 
-2,000 mast cells appeared at the injection site. By determining the proportion 
of injection sites at which the mast cell cluster appeared, the concentration of 
mast cell precursors can be calculated by limiting dilution analysis. The concen- 
tration in the peritoneal cavity was about five times as great as the concentration 
in the bone marrow. Although peritoneal mast cell precursors were shown to 
originate from  the  bone  marrow,  physical characterization revealed  that  the 
peritoneal  precursors  differed  from  the  marrow  precursors.  The  peritoneal 
precursors were less susceptible to irradiation than the marrow precursors; the 
former were heavier than the latter. When a 95% pure mast cell suspension was 
prepared from the peritoneal cells by the removal of phagocytes and the density 
gradient centrifugation, 1 out of 16 cells had the potentiality to make a mast cell 
cluster in the skin of the W/W  v mice.  Moreover, when a  single mast cell was 
identified under the phase contrast microscope and picked up with the micro- 
manipulator, 1 out of 17 mast cells  made the cluster. This indicated that some 
peritoneal mast cells kept extensive proliferative potentiality even after morpho- 
logical differentiation. In  other  words,  some peritoneal mast  cells  themselves 
may function as the committed precursors. 
Received for publication 3January 1984 and in revised  form 3 April 1984. 
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